athenahealth, Inc. (NASDAQ:ATHN) Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $130.00, for a total transaction of $104,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Brandon H. Hull also recently made the following trade(s):

  • On Friday, October 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The shares were sold at an average price of $130.00, for a total transaction of $104,000.00.
  • On Friday, September 1st, Brandon H. Hull sold 800 shares of athenahealth stock. The shares were sold at an average price of $140.95, for a total transaction of $112,760.00.

athenahealth, Inc. (NASDAQ ATHN) traded up $0.20 during mid-day trading on Tuesday, reaching $129.03. 351,800 shares of the company’s stock were exchanged, compared to its average volume of 581,146. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.67 and a current ratio of 1.67. athenahealth, Inc. has a 1 year low of $90.11 and a 1 year high of $158.66. The company has a market capitalization of $5,160.00, a PE ratio of 109.18, a price-to-earnings-growth ratio of 5.18 and a beta of 1.57.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The firm had revenue of $304.60 million during the quarter, compared to analysts’ expectations of $310.52 million. During the same period in the previous year, the business posted $0.60 earnings per share. The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. research analysts expect that athenahealth, Inc. will post 1.12 EPS for the current fiscal year.

WARNING: “Insider Selling: athenahealth, Inc. (ATHN) Director Sells 800 Shares of Stock” was published by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.dailypolitical.com/2017/11/21/insider-selling-athenahealth-inc-athn-director-sells-800-shares-of-stock.html.

A number of hedge funds have recently added to or reduced their stakes in the business. Pura Vida Investments LLC boosted its position in athenahealth by 39.1% during the third quarter. Pura Vida Investments LLC now owns 59,800 shares of the health services provider’s stock worth $7,437,000 after purchasing an additional 16,800 shares during the period. California Public Employees Retirement System boosted its position in athenahealth by 1.6% during the third quarter. California Public Employees Retirement System now owns 75,000 shares of the health services provider’s stock worth $9,327,000 after purchasing an additional 1,200 shares during the period. Perceptive Advisors LLC bought a new position in athenahealth during the third quarter worth $8,705,000. Oppenheimer Asset Management Inc. boosted its position in athenahealth by 2.4% during the third quarter. Oppenheimer Asset Management Inc. now owns 31,974 shares of the health services provider’s stock worth $3,977,000 after purchasing an additional 737 shares during the period. Finally, Jackson Square Partners LLC boosted its position in athenahealth by 55.4% during the third quarter. Jackson Square Partners LLC now owns 525,738 shares of the health services provider’s stock worth $65,380,000 after purchasing an additional 187,491 shares during the period.

A number of brokerages recently weighed in on ATHN. ValuEngine upgraded shares of athenahealth from a “sell” rating to a “hold” rating in a research report on Monday, July 24th. Cowen and Company downgraded shares of athenahealth from an “outperform” rating to a “market perform” rating and increased their price target for the company from $127.00 to $133.00 in a research report on Monday, July 31st. Wells Fargo & Company cut their price target on shares of athenahealth from $190.00 to $155.00 and set an “outperform” rating on the stock in a research report on Monday, October 23rd. Oppenheimer Holdings, Inc. reiterated a “buy” rating and issued a $184.00 price target on shares of athenahealth in a research report on Friday, October 20th. Finally, KeyCorp reiterated a “buy” rating and issued a $170.00 price target on shares of athenahealth in a research report on Sunday, September 17th. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have given a buy rating to the company’s stock. athenahealth currently has a consensus rating of “Hold” and a consensus target price of $143.22.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.